Clinical Trials Logo

Clinical Trial Summary

A Phase I clinical trialto evaluate the safety of an Inactivated Enterovirus Type 71 Vaccine in healthy children (3-11y) and infants (6-35m).


Clinical Trial Description

36 eligible children aged from 3 to 11 years and 96 eligible infants aged from 6 to 35 months will be enrolled in the study, they will be randomized to receive different dosage of vaccine candidate or placebo to evaluate the safety of this vaccine ;


Study Design


Related Conditions & MeSH terms


NCT number NCT01273246
Study type Interventional
Source Sinovac Biotech Co., Ltd
Contact
Status Completed
Phase Phase 1
Start date January 2011
Completion date July 2011

See also
  Status Clinical Trial Phase
Completed NCT01273233 - Safety of an Inactivated Enterovirus Type 71 Vaccine in Healthy Adults Phase 1